Wang Y - Search Results

1

Platelet Inhibition with Ticagrelor versus Clopidogrel in Diabetic Patients after Percutaneous Coronary Intervention for Chronic Coronary Syndromes.

Liu Z, Tian R, Wang Y, Chen Q, Li J, Xu L, Zhang S. Liu Z, et al. Among authors: wang y. Thromb Haemost. 2020 Aug;120(8):1221-1229. doi: 10.1055/s-0040-1713375. Epub 2020 Jul 15. Thromb Haemost. 2020. PMID: 32668483 Clinical Trial.

2

Initial Invasive or Conservative Strategy for Stable Coronary Disease.

Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O'Brien SM, Boden WE, Chaitman BR, Senior R, López-Sendón J, Alexander KP, Lopes RD, Shaw LJ, Berger JS, Newman JD, Sidhu MS, Goodman SG, Ruzyllo W, Gosselin G, Maggioni AP, White HD, Bhargava B, Min JK, Mancini GBJ, Berman DS, Picard MH, Kwong RY, Ali ZA, Mark DB, Spertus JA, Krishnan MN, Elghamaz A, Moorthy N, Hueb WA, Demkow M, Mavromatis K, Bockeria O, Peteiro J, Miller TD, Szwed H, Doerr R, Keltai M, Selvanayagam JB, Steg PG, Held C, Kohsaka S, Mavromichalis S, Kirby R, Jeffries NO, Harrell FE Jr, Rockhold FW, Broderick S, Ferguson TB Jr, Williams DO, Harrington RA, Stone GW, Rosenberg Y; ISCHEMIA Research Group. Maron DJ, et al. N Engl J Med. 2020 Apr 9;382(15):1395-1407. doi: 10.1056/NEJMoa1915922. Epub 2020 Mar 30. N Engl J Med. 2020. PMID: 32227755 Free PMC article. Clinical Trial.

3

Percutaneous Coronary Intervention Complexity and Risk of Adverse Events in relation to High Bleeding Risk among Patients Receiving Drug-Eluting Stents: Insights from a Large Single-Center Cohort Study.

Wang HY, Wang Y, Yin D, Gao RL, Yang YJ, Xu B, Dou KF. Wang HY, et al. Among authors: wang y. J Interv Cardiol. 2020 Apr 25;2020:2985435. doi: 10.1155/2020/2985435. eCollection 2020. J Interv Cardiol. 2020. PMID: 32405273 Free PMC article.

4

Benefit-risk profile of extended dual antiplatelet therapy beyond 1 year in patients with high risk of ischemic or bleeding events after PCI.

Wang HY, Gao RL, Xu B, Yang YJ, Yin D, Wang Y, Dou KF. Wang HY, et al. Among authors: wang y. Platelets. 2021 May 19;32(4):533-541. doi: 10.1080/09537104.2020.1774052. Epub 2020 Jun 5. Platelets. 2021. PMID: 32498587

5

Coronary Intervention Guided by Quantitative Flow Ratio vs Angiography in Patients With or Without Diabetes.

Jin Z, Xu B, Yang X, Jia R, Meng S, Hu H, Deng Y, Cao X, Ruan Y, Han J, Liu J, Qu X, Zhou Y, Wang J, Fu G, Yu B, Wang Y, Guan C, Song L, Tu S, Qiao S, Stone GW; FAVOR III China Study Group. Jin Z, et al. Among authors: wang j, wang y. J Am Coll Cardiol. 2022 Sep 27;80(13):1254-1264. doi: 10.1016/j.jacc.2022.06.044. J Am Coll Cardiol. 2022. PMID: 36137676 Free article.

6

Costs and Benefits Associated With Transradial Versus Transfemoral Percutaneous Coronary Intervention in China.

Jin C, Li W, Qiao SB, Yang JG, Wang Y, He PY, Tang XR, Dong QT, Li XD, Yan HB, Wu YJ, Chen JL, Gao RL, Yuan JQ, Dou KF, Xu B, Zhao W, Zhang X, Xian Y, Yang YJ. Jin C, et al. Among authors: wang y. J Am Heart Assoc. 2016 Apr 22;5(4):e002684. doi: 10.1161/JAHA.115.002684. J Am Heart Assoc. 2016. PMID: 27107136 Free PMC article.

7

Establishing the optimal duration of DAPT following PCI in high-risk TWILIGHT-like patients with acute coronary syndrome.

Wang HY, Mo R, Guan CD, Wang Y, Zhao YY, Xie LH, Zhang R, Cai ZX, Xu B, Dou KF. Wang HY, et al. Among authors: wang y. Catheter Cardiovasc Interv. 2022 Jan 1;99(1):98-113. doi: 10.1002/ccd.29741. Epub 2021 Apr 28. Catheter Cardiovasc Interv. 2022. PMID: 33909311

8

Quantitative flow ratio-guided strategy versus angiography-guided strategy for percutaneous coronary intervention: Rationale and design of the FAVOR III China trial.

Song L, Tu S, Sun Z, Wang Y, Ding D, Guan C, Xie L, Escaned J, Fearon WF, Kirtane AJ, Serruys PW, Wijns W, Windecker S, Leon MB, Stone GW, Qiao S, Xu B; FAVOR III China Investigators. Song L, et al. Among authors: wang y. Am Heart J. 2020 May;223:72-80. doi: 10.1016/j.ahj.2020.02.015. Epub 2020 Feb 24. Am Heart J. 2020. PMID: 32179258

9

Impact of Periprocedural Myocardial Injury and Infarction Definitions on Long-Term Mortality After Chronic Total Occlusion Percutaneous Coronary Intervention.

Song L, Wang Y, Guan C, Zou T, Sun Z, Xie L, Zhang R, Dou K, Yang W, Wu Y, Qiao S, Xu B. Song L, et al. Among authors: wang y. Circ Cardiovasc Interv. 2021 Nov;14(11):e010923. doi: 10.1161/CIRCINTERVENTIONS.121.010923. Epub 2021 Oct 22. Circ Cardiovasc Interv. 2021. PMID: 34674557

10

Benefit-Risk Profile of DAPT Continuation Beyond 1 Year after PCI in Patients with High Thrombotic Risk Features as Endorsed by 2018 ESC/EACTS Myocardial Revascularization Guideline.

Wang HY, Dou KF, Wang Y, Yin D, Xu B, Gao RL. Wang HY, et al. Among authors: wang y. Cardiovasc Drugs Ther. 2020 Oct;34(5):663-675. doi: 10.1007/s10557-020-07030-9. Epub 2020 Jun 29. Cardiovasc Drugs Ther. 2020. PMID: 32601780

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

273,930 results

Search Page